Multiple Sclerosis Management: Shedding Light on the Patient Perspective
OverviewThis industry supported symposia (ISS) will be hosted in conjunction with the 2021 Consortium of MS Center’s (CMSC) Annual Meeting.
Category
Format
  • Conference / meeting
Credits
  • AMA PRA Category 1 Credit™
  • ANCC
Event date October 28, 2021
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) -- An ACTRIMS-ECTRIMS Virtual Satellite
Overview:This case-based activity originally held as a satellite symposium in conjunction with MSVirtual2020 is designed to present several key analytic and diagnostic skills required to effectively characterize and treat neuromyelitis optica spectrum disorders (NMOSD)
Category
Format
  • Video
Credits
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Attendance
Needs Assessments: New Agents and Strategies in Parkinson’s Disease
In January 2020, Efficient distributed a survey to ascertain current practice patterns and knowledge of neurologists that manage but do not subspecialize in the care of movement disorders.
Category
Format
Credits
From Critique to Consensus: Course Evaluation
Click here to provide your feedback: From Critique to Consensus: Course Evaluation | Efficient CME
Category
Format
  • Self-study / Enduring
Credits
Part 1: Evolving Understanding of Pathophysiology and Modern Proposed Framework of Alzheimer’s Disease
Alzheimer's Disease (AD) is a unique condition in that it is widely researched with substantial representation in the literature, and yet still so much remains unknown or without consensus.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
Part 3: Diagnostic and Therapeutic Monitoring Strategies and their Potential Role in the Future of Disease-Modifying Therapy for Alzheimer’s Disease
Alzheimer's Disease (AD) is a unique condition in that it is widely researched with substantial representation in the literature, and yet still so much remains unknown or without consensus.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
From Critique to Consensus: Quantifying & Clarifying Expert Perspectives on the Future Management of Alzheimer's Disease
Alzheimer's Disease (AD) is a unique condition in that it is widely researched with substantial representation in the literature, and yet still so much remains unknown or without consensus.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
Part 2: Current Treatments and Rising Phase 3 Disease-Modifying Therapies
Alzheimer's Disease (AD) is a unique condition in that it is widely researched with substantial representation in the literature, and yet still so much remains unknown or without consensus.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
Conversations in Neurology: New Agents and Strategies for Migraine and Related Headache Disorders Edition
Program DescriptionIt has been well documented in the medical literature that despite the prevalence of migraine throughout the US population, several diagnostic and treatment gaps exist to this day.
Category
Format
  • Audio
  • Video
Credits
  • AMA PRA Category 1 Credit™
Networks in Neurology: New Agents and Strategies for Migraine
Activity Description One out of six US adults suffer from migraines and yet, until recently, management has been reliant on treatments designed for other conditions that had some consequential success.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™

Pages